Jennifer Pietenpol

January 17, 2017

Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country.

By VUMC News and Communications
December 1, 2016

Basic Science Research Advisory Committee formed

Vanderbilt University School of Medicine (VUSM) has formed a new Basic Science Research Advisory Committee.

By John Howser
September 9, 2016

VICC leaders active in new Cancer Moonshot recommendations

As part of the national Cancer Moonshot initiative, a Blue Ribbon Panel (BRP) of cancer leaders, including four from Vanderbilt-Ingram Cancer Center, has delivered a series of recommendations to accelerate the pace of cancer prevention efforts and scientific discovery.

By VUMC News and Communications
September 9, 2016

In search of new cancer targets

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

By Leigh MacMillan
July 14, 2016

Initiative set to sharpen VUMC’s strategic focus

With the transition of Vanderbilt University Medical Center (VUMC) into a new financial and legal entity now complete, Medical Center leaders view this period as an opportunity to sharpen the organization’s strategic focus.

By John Howser
June 2, 2016

13 cross-college collaborative projects win TIPs funding

Thirteen interdisciplinary projects, ranging from cellular processes and smart cities to global health care issues, have been selected as the 2016 awardees of the Trans-Institutional Program (TIPs) initiative.

By VUMC News and Communications
May 26, 2016

Precision medicine already changing cancer treatment strategies

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.
By VUMC News and Communications
April 27, 2016

Public invited to learn about VICC precision cancer medicine

Leading cancer investigators from Vanderbilt-Ingram Cancer Center will unveil the latest in cancer research during a community event May 10.
By VUMC News and Communications
April 14, 2016

Pietenpol named Executive Vice President for Research

Jennifer Pietenpol, Ph.D., director of the Vanderbilt-Ingram Cancer Center, B.F. Byrd Jr. Professor of Molecular Oncology and Professor of Biochemistry, Cancer Biology and Otolaryngology, has been named Executive Vice President for Research at Vanderbilt University Medical Center (VUMC). Her appointment is effective May 1.
By John Howser
April 7, 2016

Pietenpol named to NCI Blue Ribbon Panel

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), has been selected to serve on a Blue Ribbon Panel that will inform the scientific direction and goals at the National Cancer Institute (NCI) for Vice President Joe Biden’s National Cancer Moonshot Initiative.
By VUMC News and Communications
April 1, 2016

New role identified for p73 gene

The p73 gene is required for the generation of cilia – hair-like projections on cells – findings that could have implications for the study of lung diseases and sterility.
By VUMC News and Communications
March 17, 2016

T.J. Martell Foundation lauds Pietenpol’s research

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center (VICC), was honored with the Medical Research Advancement Award during the 8th Annual T.J. Martell Foundation Nashville Honors Gala held recently at the Omni Nashville Hotel.
By VUMC News and Communications
October 8, 2015

Komen, VICC partnership bolsters breast cancer research

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support.
By VUMC News and Communications
1 2 3 4 5